Verdiva Bio Limited ("Verdiva Bio" or "the Company"), a clinical-stage biotechnology company advancing a scalable, once-weekly oral obesity product pipeline, today announced that two abstracts have ...

Fruit is recommended as part of a healthy diet for people with diabetes. The best fruit for blood sugar control includes ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that three late-breaking abstracts highlighting its ...

The American Animal Hospital Association (AAHA) released the 2026 AAHA Diabetes Management Guidelines for Cats, marking the ...

An investigational obesity drug from Eli Lilly cleared important end points in a late-stage trial, the company said Thursday, ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...

Researchers have discovered in a new 10-year retrospective study that laparoscopic one-anastomosis gastric bypass achieved ...

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Lilly’s triple agonist, retatrutide, delivered powerful weight loss in pivotal phase 3 obesity trial: Our Bureau, Mumbai Friday, May 22, 2026, 17:15 Hrs [IST] Eli Lilly and Comp ...

A new study led by researchers at the UMass Amherst suggests that more than half of type 2 diabetes cases could be prevented ...

Spot, prevent, and manage type 2 diabetes with simple tests and practical diet/exercise steps.

Copenhagen, Denmark, 21 May2026 - Antag Therapeutics ('Antag” or 'the Company”), advancing personalized and flexible obesity ...